Live Breaking News & Updates on Hyderabad based pharmaceutical

Stay updated with breaking news from Hyderabad based pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biological E's 14-Valent Pneumococcal Conjugate Vaccine

Hyderabad: Hyderabad-based Pharmaceutical and Vaccine Company Biological E. Limited (BE), announced its Pharmaceutical and Vaccine Company that its 14-valent paediatric Pneumococcal Conjugate Vaccine, (Investigational Pneumococcal Polysaccharide Conjugate Vaccine PCV14) against S. pneumoniae infection received approval from the Drugs Controller General of India (DCGI) for

India , Hyderabad , Andhra-pradesh , Mahima-datla , Vaccine-company , Vaccine-company-biologicale-limited , Hyderabad-based-pharmaceutical , Vaccine-company-biological , Pneumococcal-conjugate-vaccine , Drugs-controller-general , Managing-director , Dcgi

DCGI approves 14-valent pneumococcal conjugate vaccine

Biological E. Limited (BE), a Hyderabad-based Pharmaceutical and Vaccine Company Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine, (Investigational Pneumococcal Polysaccharide Conjugate Vaccine PCV14) against S. ...

India , Hyderabad , Andhra-pradesh , Mahima-datla , Vaccine-company , E-limited , Hyderabad-based-pharmaceutical , Vaccine-company-friday , Pneumococcal-conjugate-vaccine , Drugs-controller-general , Managing-director ,

Granules India's Q2 net profit up 80 pc at INR 145 cr

Uniindia: Hyderabad, Oct 20 (UNI) Granules India’s net profit increased by 80 per cent at INR 145 crore in the second quarter ended September 30,2022 as against INR 81 crore in the corresponding period in the previous year.

United-states , India , Hyderabad , Andhra-pradesh , Krishna-prasad-chigurupati , Pharmaceuticals-ingredients , Granules-india , Hyderabad-based-pharmaceutical , Pharmaceutical-formulation-intermediates , Managing-director , Granules-india-limited , Business

Biological E's Corbevax vaccine granted approval for use in children aged 12-18

The move makes Corbevax the second covid vaccine to be approved for administration to children in India

Hyderabad , Andhra-pradesh , India , National-technical-advisory-group , Drugs-controller-general , Hyderabad-based-pharmaceutical , Receptor-binding-domain , Corbevax , Corbevax-covid-vaccine , Corbevax-vaccine , Orbevax-biological-e

Biological E's Corbevax vaccine granted approval for use in children aged 12-18

The move makes Corbevax the second covid vaccine to be approved for administration to children in India

Hyderabad , Andhra-pradesh , India , National-technical-advisory-group , Drugs-controller-general , Hyderabad-based-pharmaceutical , Receptor-binding-domain , Corbevax , Corbevax-covid-vaccine , Corbevax-vaccine , Orbevax-biological-e

Corbevax COVID vaccine is safe, offers high antibody levels: NTAGI chief

The remarks came after DCGI recommended Emergency Use Authorization to Biological E's vaccine, Corbevax

India , New-delhi , Delhi , National-technical-advisory-group , India-subject-expert-committee , Serum-institute , Drugs-controller-general , Subject-expert-committee , Emergency-use-authorization , Hyderabad-based-pharmaceutical , Corbevax

Corbevax COVID vaccine is safe, offers high antibody levels: NTAGI chief

The remarks came after DCGI recommended Emergency Use Authorization to Biological E's vaccine, Corbevax

India , New-delhi , Delhi , National-technical-advisory-group , India-subject-expert-committee , Serum-institute , Drugs-controller-general , Subject-expert-committee , Emergency-use-authorization , Hyderabad-based-pharmaceutical , Corbevax

Corbevax COVID vaccine is safe, offers high antibody levels: NTAGI chief

The remarks came after DCGI recommended Emergency Use Authorization to Biological E's vaccine, Corbevax

India , New-delhi , Delhi , National-technical-advisory-group , India-subject-expert-committee , Serum-institute , Drugs-controller-general , Subject-expert-committee , Emergency-use-authorization , Hyderabad-based-pharmaceutical , Corbevax

NTAGI chief says Corbevax Covid vaccine is safe, provides high antibody levels

NTAGI chief says Corbevax Covid vaccine is safe, provides high antibody levels - The country’s central drug authority is soon expected to give final approval to Corbevax, which is a two-dose vaccine.

India , National-technical-advisory-group , India-subject-expert-committee , Serum-institute , Drugs-controller-general , Subject-expert-committee , Emergency-use-authorization , Hyderabad-based-pharmaceutical , Covid-19 , Ovid-vaccine , Orbevax

Hetero announces interim phase III clinical trial results for Molnupiravir conducted in India

Hetero announces interim phase III clinical trial results for Molnupiravir conducted in India
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , United-states , Merck-co-inc , Indian-council-of-medical-research , Hyderabad-based-pharmaceutical , Indian-council , Medical-research , Active-pharmaceutical-ingredients , ஹைதராபாத்